target directory

kamlanoflast is hypothesized to target neuroinflammatory pathways associated with amyotrophic lateral sclerosis als clinical trial intelligence

Trials are included when the normalized target field matches this target directory. Full protocol, result, eligibility and IP analysis is available inside the premium workspace.